Igal Moarof

538 total citations
11 papers, 340 citations indexed

About

Igal Moarof is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Igal Moarof has authored 11 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Igal Moarof's work include Coronary Interventions and Diagnostics (7 papers), Cardiac Valve Diseases and Treatments (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Igal Moarof is often cited by papers focused on Coronary Interventions and Diagnostics (7 papers), Cardiac Valve Diseases and Treatments (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Igal Moarof collaborates with scholars based in Switzerland, Canada and Italy. Igal Moarof's co-authors include Stephan Windecker, Marco Roffi, Dik Heg, Olivier Müller, Thomas Pilgrim, Daniel Weilenmann, Christoph Kaiser, Peter Jüni, Stéphane Cook and Juan F. Iglesias and has published in prestigious journals such as The Lancet, PLoS ONE and Journal of the American Heart Association.

In The Last Decade

Igal Moarof

11 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Igal Moarof Switzerland 9 276 253 93 50 27 11 340
Daiji Hasegawa Japan 12 199 0.7× 251 1.0× 89 1.0× 124 2.5× 30 1.1× 24 356
Suguru Otsuru Japan 11 250 0.9× 182 0.7× 98 1.1× 119 2.4× 17 0.6× 28 294
Jung-Won Suh South Korea 5 208 0.8× 252 1.0× 64 0.7× 56 1.1× 12 0.4× 10 307
Aurélie Veugeois France 7 274 1.0× 214 0.8× 106 1.1× 111 2.2× 22 0.8× 22 329
Antoni Serra Spain 7 372 1.3× 346 1.4× 125 1.3× 116 2.3× 84 3.1× 15 460
Martijn Scholte Netherlands 10 367 1.3× 299 1.2× 98 1.1× 56 1.1× 5 0.2× 15 411
Evangelia Vemmou United States 10 266 1.0× 178 0.7× 91 1.0× 138 2.8× 11 0.4× 42 314
Darius Dudek Poland 8 139 0.5× 155 0.6× 50 0.5× 55 1.1× 23 0.9× 21 237
Serruys Pw Netherlands 10 200 0.7× 158 0.6× 83 0.9× 113 2.3× 41 1.5× 42 286
Giuseppe Calligaris Italy 10 182 0.7× 139 0.5× 149 1.6× 84 1.7× 54 2.0× 30 320

Countries citing papers authored by Igal Moarof

Since Specialization
Citations

This map shows the geographic impact of Igal Moarof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igal Moarof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igal Moarof more than expected).

Fields of papers citing papers by Igal Moarof

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igal Moarof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igal Moarof. The network helps show where Igal Moarof may publish in the future.

Co-authorship network of co-authors of Igal Moarof

This figure shows the co-authorship network connecting the top 25 collaborators of Igal Moarof. A scholar is included among the top collaborators of Igal Moarof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igal Moarof. Igal Moarof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wagener, Max, Oliver Reuthebuch, Dik Heg, et al.. (2023). Clinical Outcomes in High‐Gradient, Classical Low‐Flow, Low‐Gradient, and Paradoxical Low‐Flow, Low‐Gradient Aortic Stenosis After Transcatheter Aortic Valve Implantation: A Report From the SwissTAVI Registry. Journal of the American Heart Association. 12(12). e029489–e029489. 21 indexed citations
2.
Piccirelli, Marco, Athina Pangalu, Dominik Straumann, et al.. (2021). Assessment of Retinal Capillary Dropout after Transcatheter Aortic Valve Implantation by Optical Coherence Tomography Angiography. Diagnostics. 11(12). 2399–2399. 8 indexed citations
3.
Pilgrim, Thomas, Olivier Müller, Dik Heg, et al.. (2021). Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI. JACC: Cardiovascular Interventions. 14(6). 639–648. 30 indexed citations
4.
5.
Iglesias, Juan F., Dik Heg, Marco Roffi, et al.. (2019). Five‐Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus‐Eluting Stents Versus Durable Polymer Everolimus‐Eluting Stents. Journal of the American Heart Association. 8(22). e013607–e013607. 12 indexed citations
6.
Iglesias, Juan F., Dik Heg, Marco Roffi, et al.. (2019). Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. Circulation Cardiovascular Interventions. 12(8). e008024–e008024. 21 indexed citations
7.
8.
Nietlispach, Fabian, Igal Moarof, Maurizio Taramasso, Francesco Maisano, & Bernhard Meier. (2017). Left atrial appendage occlusion. EuroIntervention. 13(AA). AA78–AA84. 7 indexed citations
9.
Taramasso, Maurizio, Fabian Nietlispach, Danny Dvir, et al.. (2016). Transfemoral tricuspid valve-in-valve implantation: snare it to make it simpler!. EuroIntervention. 12(3). 402–402. 3 indexed citations
10.
Csordás, Adam, Fabian Nietlispach, Philipp Schüetz, et al.. (2015). Midregional Proadrenomedullin Improves Risk Stratification beyond Surgical Risk Scores in Patients Undergoing Transcatheter Aortic Valve Replacement. PLoS ONE. 10(12). e0143761–e0143761. 14 indexed citations
11.
Eshtehardi, Parham, et al.. (2008). Giant Coronary Artery Aneurysm. Circulation Cardiovascular Interventions. 1(1). 85–86. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daiji Hasegawa Breakdown of academic impact, for papers by Suguru Otsuru Breakdown of academic impact, for papers by Jung-Won Suh Breakdown of academic impact, for papers by Aurélie Veugeois Breakdown of academic impact, for papers by Antoni Serra Breakdown of academic impact, for papers by Martijn Scholte Breakdown of academic impact, for papers by Evangelia Vemmou Breakdown of academic impact, for papers by Darius Dudek Breakdown of academic impact, for papers by Serruys Pw Breakdown of academic impact, for papers by Giuseppe Calligaris
Rankless by CCL
2026